Celestial Biolabs (Delisted) share price

BSE: 532871Pharmaceuticals & Biotechnology

Celestial Biolabs Limited · Formerly Celestial Labs · Face value ₹10 · Listed Jul 2007

Last traded ₹1.75 on 11 Mar 2020

Delisted on 16 Oct 2024.

Last announcements

The company's own last announcements before its shares stopped trading, routine notices left out.

  1. Oct 2024

    • 16 Oct · Delisting

      Members of the Exchange are hereby informed about the delisting of equity shares of Celestial Biolabs Limited w.e.f. October 17, 2024 in terms of Rule 21(2) (b) of the Securities Contracts (Regulations) Rules 1957.
  2. Jul 2024

  3. May 2024

Share price history

Daily closes since Jul 2007, BSE closes in Jul 2007, Jul 2007 to Feb 2008, Feb 2008 to May 2008 and May 2008 to Jul 2010, adjusted for splits and bonuses

Daily close, ₹ per share

Q3 results, quarter to Dec 2023

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

Revenue
₹0.04 Cr+8.9% on a year ago · +2.8% on the quarter before
Operating profit
−₹0.03 Cr
Net profit
−₹0.03 Cr
Earnings per share
−₹0.02
Operating margin
−76.9%
Net margin
−93.5%

From revenue to net profit, ₹ crore

  1. Revenue0.0
  2. Materials and goods0.0
  3. Employee costs0.0
  4. Other expenses0.0
  5. Operating profit0.0
  6. Depreciation0.0
  7. Other income0.0
  8. Finance costs0.0
  9. Profit before tax0.0
  10. Tax0.0
  11. Net profit0.0

Celestial Biolabs results by quarter

Standalone: the listed company alone, without its subsidiaries. Latest quarter to Dec 2023. Results for the quarter to Mar 2024 were due by 30 May 2024, 60 days after it ends. Every company's dates are on the results calendar.

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
  • Loss
0−0.1Mar 210−0.1Jun 210.00.0Sep 210.00.0Dec 21Mar 220.1−0.1Jun 220.0−0.1Sep 220.0−0.2Dec 220.0−0.2Mar 230.0−0.1Jun 230.00.0Sep 230.00.0Dec 23
Peak revenue ₹0.06 Cr, quarter to Jun 2022; lowest ₹0.00 Cr, quarter to Mar 2021A loss in 11 of the 11 quarters with results on record

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
−47.9%−622.4%−47.9%−111.3%−169.9%−177.5%−429.0%−602.9%−411.1%−74.9%−76.9%−64.1%−131.2%−184.0%−195.9%−451.8%−622.4%−436.7%−91.1%−93.5%Mar 21Sep 21Mar 22Sep 22Mar 23Sep 23Dec 23
₹ croreMar 2019Jun 2019Q1Sep 2019Dec 2019Q3Mar 2020Jun 2020Q1Sep 2020Dec 2020Q3Mar 2021Jun 2021Q1Sep 2021Dec 2021Q3Mar 2022Jun 2022Q1Sep 2022Dec 2022Q3Mar 2023Jun 2023Q1Sep 2023Dec 2023Q3
Revenue from operations3.04.30.70.30.00.00.00.00.00.00.00.0–0.10.00.00.00.00.00.0
−0.82.997.90.30.20.10.00.00.10.00.10.1–0.10.10.20.30.10.10.1
Materials and goods bought−2.52.50.50.20.00.00.00.00.00.00.00.0–0.00.00.00.00.00.00.0
Employee costs0.20.20.00.00.00.00.00.00.00.00.00.0–0.00.00.10.10.00.00.0
Other expenses1.50.297.40.00.20.10.00.00.10.00.00.0–0.10.00.10.20.10.00.0
Operating profit before depreciation3.81.4−97.30.0−0.2−0.10.00.0−0.10.00.00.0–−0.1−0.1−0.1−0.2−0.10.00.0
Operating margin127.2%31.6%−14,626.8%−3.6%––––––−47.9%−111.3%–−169.9%−177.5%−429.0%−602.9%−411.1%−74.9%−76.9%
Depreciation and amortisation3.72.20.00.00.00.00.00.00.00.00.00.0–0.00.00.00.00.00.00.0
Other income0.30.00.00.00.00.00.00.00.00.00.00.0–0.00.00.00.00.00.00.0
Finance costs1.00.10.40.40.40.00.00.00.00.00.00.0–0.00.00.00.00.00.00.0
One-off items0.00.00.00.00.00.00.00.00.00.00.00.0–0.00.00.00.00.00.00.0
Profit before tax−0.5−1.0−97.7−0.5−0.6−0.10.00.0−0.1−0.10.00.0–−0.1−0.1−0.2−0.2−0.10.00.0
Tax0.00.00.00.0−1.40.00.00.00.00.00.00.0–0.00.00.00.00.00.00.0
Net profit−0.5−1.0−97.7−0.50.8−0.10.00.0−0.1−0.10.00.0–−0.1−0.1−0.2−0.2−0.10.00.0
Net margin−18.1%−23.4%−14,693.4%−154.7%––––––−64.1%−131.2%–−184.0%−195.9%−451.8%−622.4%−436.7%−91.1%−93.5%
Earnings per share−₹0.24−₹0.44−₹43.26−₹0.20₹0.36−₹0.03−₹0.01−₹0.01−₹0.03−₹0.02−₹0.01−₹0.02–−₹0.04−₹0.04−₹0.07−₹0.10−₹0.04−₹0.01−₹0.02
Earnings per share in rupees, restated for later splits and bonuses. No results on record for the quarter to Mar 2022.

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
240.8Mar 14Mar 15Mar 16393.3Mar 17433.5Mar 18490.07.8Mar 195.2−988.2Mar 200−0.28.2Mar 21Mar 220.2−0.612Mar 23
Peak revenue ₹49 Cr, year to Mar 2019; lowest ₹0.00 Cr, year to Mar 2021A loss in 4 of the 7 years with results on record

Operating and net margin, per cent

  • Operating margin
  • Net margin
24.0%−1,880.9%24.0%−1,838.1%−320.9%3.6%8.6%8.1%−0.1%−1,880.9%−339.0%Mar 14Mar 16Mar 18Mar 20Mar 22Mar 23

Results for the year to Mar 2023

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue0.2
  2. Materials and goods−0.1
  3. Employee costs−0.2
  4. Other expenses−0.4
  5. Operating profit−0.5
  6. Depreciation0.0
  7. Other income0.0
  8. One-off items0.0
  9. Finance costs0.0
  10. Profit before tax−0.6
  11. Tax0.0
  12. Net profit−0.6

What the company owns

  • Plant, investments and other assets₹13 Cr
  • Receivables₹4 Cr
  • Inventory₹0 Cr
  • Cash and bank₹0 Cr

What pays for it: net worth and liabilities

  • Borrowings₹12 Cr
  • Net worth₹3 Cr
  • Other liabilities₹2 Cr
  • Owed to suppliers₹0 Cr

Profit and loss

Standalone, ₹ crore, years to March. No results on record for the years to Mar 2015, Mar 2016 and Mar 2022. The last column is the twelve months to Dec 2023, the latest four quarters added.

₹ croreMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Dec 2023Twelve months
Revenue from operations24––39434950–00
–––––371010–11
Materials and goods bought11––8292930–00
Employee costs–––––100–00
Other expenses–––––7980–00
Operating profit before depreciation–––––12−960–−10
Operating margin–––––24.0%−1,838.1%––−320.9%−282.9%
Materials, % of revenue–––––58.6%62.5%––62.9%63.5%
Employee costs, % of revenue–––––3.0%5.2%––118.8%119.9%
Other expenses, % of revenue–––––14.4%1,870.4%––239.2%199.5%
Depreciation and amortisation–––38920–00
Operating profit after depreciation–––––2−980–−10
Other income–––––000–00
Finance costs2––00110–00
One-off items–––––000–00
Profit before tax1––441−1000–−10
0––111−10–00
Net profit1––330−980–−10
Net margin3.6%––8.6%8.1%−0.1%−1,880.9%––−339.0%−301.7%
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2014: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2017 and Mar 2018: revenue, other income and exceptional items less the total expenses stated do not come to the profit before tax the same statement states, so the operating expenses cannot be told apart from the rest.
Earlier years, Mar 2008 to Mar 2013
₹ croreMar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013
Revenue from operations19.919.324.625.220.621.2
10.511.616.921.3––
Materials and goods bought–––0.97.59.2
Operating profit before depreciation9.47.77.73.9––
Operating margin47.3%40.0%31.2%15.4%––
Depreciation and amortisation0.30.30.50.5––
Operating profit after depreciation9.27.47.23.4––
Other income0.3––0.10.40.0
Finance costs0.00.10.00.20.70.7
Profit before one-off items and tax–7.37.13.20.30.3
One-off items–––−0.6––
Profit before tax9.57.37.12.60.30.3
Tax0.00.11.2–−0.60.1
Net profit9.47.25.92.60.90.7
Net margin47.2%37.2%24.1%10.4%4.4%3.4%
Standalone, ₹ crore, years to March.

Balance sheet

Standalone, ₹ crore, at 31 March. The last column is the half year to Sep 2023, after the latest full year: the balance sheet at its end.

₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023Half year
10244–33
Share capital232323–2323
Reserves80−19−19–−20−20
888–1212
855–55
988–99
Total assets1191717–1717
971313–1313
2344–44
Net debt888–1212
Borrowings are counted again inside the liabilities due within a year and after a year. Plant in use and plant being built are given for full years only. No balance sheet is on record for the years to Mar 2014, Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March. The last column is the half year to Sep 2023, after the latest full year: the cash flow over its six months.

₹ croreMar 2020Mar 2021Mar 2022Mar 2023Sep 2023Half year
−3.10.0–−0.30.0
15.60.1–0.20.1
Receivables11.80.0–0.10.0
Inventories6.10.0–0.00.0
Payables−0.20.0–0.00.1
Other working capital−2.10.0–0.10.0
Capital spending4.10.0–0.00.0
Free cash flow−7.20.0–−0.40.0
Cash from investing4.10.0–0.00.0
−1.10.0–0.40.0
Dividends paid0.00.0–0.00.0
Shares bought back0.00.0–0.00.0
Shares issued0.00.0–0.00.0
Net change in cash0.00.0–0.00.0
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2014, Mar 2017, Mar 2018 and Mar 2019.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Earnings per share₹1.48₹1.53−₹0.01−₹43.54−₹0.08–−₹0.25
Diluted earnings per share₹1.48₹1.53−₹0.01−₹43.54−₹0.08–−₹0.25
Book value per share–––₹1.74₹1.66–₹1.23
Shareholder yield–––0.0%–––
Market cap at the year end (₹ crore)–––3.95–––

Ratios

Standalone, years to March.

RatioMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Revenue growth11.1%–––10.7%14.4%−89.3%−100.0%––
Net profit growth19.0%–––3.7%–––––
Earnings per share growth––––3.4%–––––
–––––0.0%−185.2%––−20.6%
––––––−185.2 pts–––
From the net margin––––––−900.7 pts–––
From asset turnover––––––732.7 pts–––
From borrowing––––––−17.2 pts–––
Return on capital employed–––––2.1%−812.2%−1.7%–−3.9%
Interest cover–––––1.8––––
Debt to equity–––––0.082.082.19–4.29
Receivable days–––––117267––8,022
Inventory days–––––786––116
Payable days–––––738––920
Cash conversion cycle, days–––––187235––7,219
Working capital days–––––110−62––3,839
Asset turnover–––––0.410.080.00–0.01
Assets per rupee of net worth–––––1.171.294.48–6.13
Sales per rupee of plant–––––0.9531.250.00–2.11
Capital spending to depreciation––––––1.810.00–0.23
Plant being built, % of plant in use–––––57.4%7,660.4%10,012.3%–16,059.9%
Interest cover is left blank for the years to Mar 2020 and Mar 2023: operating profit after depreciation is a loss, and a loss covers no interest bill. No balance sheet is on record for the years to Mar 2014, Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2023.

Return on assets, latest year
−3.4%
Measure10 years5 years3 years
Revenue growth, yearly rate−38.3%−67.0%−68.2%
Return on capital employed, average–−203.9%−2.8%
Asset turnover, average–0.120.01
Debt to equity, average–2.163.24

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2023.

₹ croreLatest year
Cash from operations−0.35
Cash from investing−0.01
Cash from financing0.37
Capital spending0.01
Dividends paid0.00
Shares bought back0.00
Shares issued for cash0.00
Borrowings raised0.37
Borrowings repaid0.00

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Beneish M-scorePublished threshold −1.78––––––−47.53–––
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––––−145.52−0.80––
Receivables growth less revenue growthOur threshold 0 percentage points––––––13.7998.80––
Inventory growth less cost-of-goods growthOur threshold 0 percentage points––––––−10.54100.00––
Other current assets growth less revenue growthOur threshold 5 per cent of revenue––––––7.16–––
Effective tax ratePublished threshold 17.16 per cent18.99––17.3518.47102.01––––
A threshold marked as ours has no published figure; it is the line we read the check against.

Business segments

In the year to Mar 2023 the company reports one business segment, Pharmaceuticals, which carries all its revenue.

Who owns Celestial Biolabs, filing by filing

Per cent of the company's shares. Every filing on record, from Sep 2019; the latest is the filing for Mar 2024.

Mar 2024 filing

  • Promoters26.07%
  • Individuals and others73.93%

Shareholding pattern, per cent, from Sep 2022

  • Promoters
  • Individuals and others
73.93%26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%73.93%73.93%73.93%73.93%73.93%73.93%73.93%Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24
Per centSep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%
Indian promoters26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%26.07%
73.93%73.93%73.93%73.93%73.93%73.93%73.93%73.93%73.93%73.93%73.93%73.93%73.93%73.93%73.93%73.93%73.93%73.93%73.93%
Shares in issue2,25,86,3502,25,86,3502,25,86,3502,25,86,3502,25,86,3502,25,86,3502,25,86,3502,25,86,3502,25,86,3502,25,86,3502,25,86,3502,25,86,3502,25,86,3502,25,86,3502,25,86,3502,25,86,3502,25,86,3502,25,86,3502,25,86,350
Shares locked in68,83,57368,83,57368,83,57368,83,57368,83,57368,83,57368,83,57368,83,57368,83,57368,83,57368,83,57368,83,57368,83,57368,83,57368,83,57368,83,57368,83,57368,83,57368,83,573
Promoters' shares locked in58,88,96358,88,96358,88,96358,88,96358,88,96358,88,96358,88,96358,88,96358,88,96358,88,96358,88,96358,88,96358,88,96358,88,96358,88,96358,88,96358,88,96358,88,96358,88,963
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state.

Number of Celestial Biolabs shareholders

Shareholders on the company's register in each filing.

Shareholders, filing by filing

12,779Sep 1912,968Dec 1912,575Mar 2012,579Jun 2012,596Sep 2012,589Dec 2012,588Mar 2112,579Jun 2112,572Sep 2112,564Dec 2112,558Mar 2212,553Jun 2212,548Sep 2212,539Dec 2212,534Mar 2312,533Jun 2312,530Sep 2312,530Dec 2312,523Mar 24
ShareholdersSep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
All shareholders12,77912,96812,57512,57912,59612,58912,58812,57912,57212,56412,55812,55312,54812,53912,53412,53312,53012,53012,523
5555555555555555555
Indian promoters5555555555555555555
12,77412,96312,57012,57412,59112,58412,58312,57412,56712,55912,55312,54812,54312,53412,52912,52812,52512,52512,518
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state.

Celestial Biolabs promoters

Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Mar 2024; the largest is ADITYA NARAYAN SINGH, 12.20%.

Holder
ADITYA NARAYAN SINGHIndividuals and Hindu undivided families12.20%27,55,3500.00%100.00%
PADMA SINGHIndividuals and Hindu undivided families5.19%11,73,0350.00%100.00%
NITIN KUMAR SINGHIndividuals and Hindu undivided families4.63%10,46,3280.00%100.00%
AMIT KUMAR SINGHIndividuals and Hindu undivided families3.38%7,64,2500.00%100.00%
ANITA SINGHIndividuals and Hindu undivided families0.66%1,50,0000.00%100.00%
Pledged is the share of the holder's own shares pledged to a lender. Locked in is the share of the holder's own shares that cannot be sold yet, as after a listing or an allotment.

Largest public holders of Celestial Biolabs, filing by filing

Per cent, on the same shares as the split above.

HolderSep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
SANGEETHA SResident individuals, over ₹2 lakh at face value–4.04%4.04%4.04%4.04%4.04%4.04%4.04%4.04%4.04%4.04%4.04%4.04%4.04%4.04%4.04%4.04%4.04%4.04%
AJAY KUMAR SINGHResident individuals, over ₹2 lakh at face value1.25%1.66%2.08%2.08%2.08%2.08%2.08%2.08%2.08%2.08%2.08%2.08%2.08%2.08%2.08%2.08%2.08%2.08%2.08%
CHANDRASHEKHAR RAM VAIDYAResident individuals, over ₹2 lakh at face value––––––––––––––––––1.16%
C R VAIDYANon-resident Indians––––––––––––1.16%––––––
ASHOK KIRTANLAL SHAHResident individuals, over ₹2 lakh at face value1.20%1.20%–––––––––––––––––
SUBRAMANIAN PResident individuals, over ₹2 lakh at face value4.04%––––––––––––––––––
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.

Who moved in the Mar 2024 filing

Against the Dec 2023 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.

  • Individuals and others: CHANDRASHEKHAR RAM VAIDYA newly named at 1.16%

Celestial Biolabs share price by year

Each calendar year to 2020.

YearClose at year endChangeHighest closeLowest close
20201.75−34.0%3.351.75
20192.65−69.7%8.702.65
20188.75−58.5%22.307.40
201721.10+3.4%28.4517.05
201620.40−44.1%38.6518.25
201536.50−9.7%74.7014.45
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The 2020 close is its last trade, on 11 Mar 2020.

Recent sessions

The 10 trading days to 11 Mar 2020, as traded on BSE.

DateOpenHighLowCloseAverage priceVolume
11 Mar 20201.801.801.751.751.768,324
9 Mar 20201.851.851.801.801.83880
6 Mar 20201.851.851.851.851.854,007
5 Mar 20201.851.901.851.851.8515,769
4 Mar 20201.901.901.901.901.902,954
3 Mar 20201.851.951.851.951.853,296
2 Mar 20202.002.001.901.901.942,306
28 Feb 20202.002.002.002.002.004,387
27 Feb 20202.102.102.002.052.09532
26 Feb 20202.002.102.002.102.074,264
Prices in ₹ per share as traded, not adjusted.

Price adjustments

What the price chart is corrected for, so it reads as one share held throughout.

Ex-dateEventPrice factorWhat happened
8 Oct 2018Price move–Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for.
27 May 2015Price move–Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for.
Each event is noted and not adjusted for.

Company details

BSE code
532871
ISIN
INE221I01017
Industry
Pharmaceuticals & Biotechnology
Former symbols
CELESTIAL
CIN
L72200TG1997PLC028374
Corporate identity number, the registrar of companies' code for it
Incorporated
1997
Registered office
Plot No 82, Venkat Reddy Nagar, Narapally, Medchal - Malkajgiri Dist., Hyderabad 500039, Telangana
Share registrar
KFin Technologies Ltd
Keeps the register of shareholders and handles transfers and dividend payments